Nutritional support ingredients containing boron esters and their production method
A food supplement combining glucosamine-chondroitin sulfate and boron esters addresses the ineffectiveness of current osteoarthritis treatments by enhancing joint health and bioavailability, offering a safer and more effective option for osteoarthritis and osteoporosis management.
Patent Information
- Application Number
- PCT/TR2024/050480
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-05-15
- Publication Date
- 2024-12-05
AI Technical Summary
Current treatments for osteoarthritis and osteoporosis are ineffective and have significant side effects, and there is a need for more effective therapeutic agents to prevent or delay articular cartilage destruction.
A food supplement containing glucosamine-chondroitin sulfate and boron esters, which are bio-active borate esters of mono-chelate and bis-chelate complexes formed from boric acid and hydroxy-functional biomolecules, are developed to enhance joint health and bioavailability of essential vitamins and minerals, with specific synthesis methods to ensure stability and absorption.
The supplement effectively reduces pain, improves joint function, and enhances bone health, while having fewer side effects compared to traditional treatments, and is shown to inhibit collagenase enzymes and support apoptosis, demonstrating synergistic effects with glucosamine and chondroitin sulfate.
Smart Images

Figure 000010 
Figure 000011 
Figure 000012
Abstract
Description
[0001] NUTRITIONAL SUPPORT INGREDIENTS CONTAINING BORON ESTERS AND THEIR PRODUCTION METHOD
[0002] TECHNICAL FIELD
[0003] The invention relates to a food supplement containing glucosamine-chondritin sulfate and boron esters, and to a method of producing the food supplement.
[0004] BRIEF DESCRIPTION OF THE INVENTION
[0005] Glucosamine is an amino sugar and an important precursor in the biochemical synthesis of glycosylated proteins and lipids. It is part of the structure of two polysaccharides, chitosan and chitin. Most glucosamine is produced by processing chitin from the shells of shellfish such as shrimp, lobster and crab. To meet the demands of vegetarians and others who object to shellfish, manufacturers have introduced glucosamine products derived from using the fungus Aspergillus niger and fermenting corn.
[0006] Glucosamine is one of the most abundant monosaccharides. Glucosamine occurs naturally in shellfish, animal bones, bone marrow and the shells of fungi. D- Glucosamine is made naturally in the form of glucosamine-6-phosphate and is the biochemical precursor of all nitrogen-containing sugars.
[0007] Perhaps the most important aspect of glucosamine and chondroitin sulfate supplements is that they are thought to help slow or prevent the degeneration of joint cartilage, the underlying cause of osteoarthritis pain. Glucosamine and chondroitin sulfate dietary supplements may also help relieve existing joint pain. Currently, unlike many medications available to treat arthritis pain and inflammation, glucosamine and chondroitin sulfate supplements are thought to have very few side effects.
[0008] Currently, there are no officially approved drugs that prevent or delay the progression of articular cartilage destruction such as osteoporosis, osteoarthritis and existing pharmacologic therapies are often ineffective due to concerns about their limited efficacy and long-term side effects.Therefore, there is a significant need for more effective therapeutic agents for the treatment of articular cartilage destruction such as osteoporosis, osteoarthritis. While researching various boron compounds, scientists discovered boron esters, the plant form of boron found naturally in fruits, vegetables and other foods. Studies have shown that boron esters reduce pain associated with osteoarthritis, positively affect bone health and increase joint function. Boron esters are compounds formed by the interaction of boric acid with an organic biomolecule having a cis-diol group (two adjacent -OH groups) and a water molecule separating between them. Figure 5 shows a schematic representation of the cis-diol group.
[0009] In humans, diets containing boron supplements have also been shown to be associated with improved performance on tasks measuring dexterity, perception and long-term memory. Boron esters have been shown to inhibit the activity of collagenase enzymes. These enzymes are naturally produced in human biochemistry, break down collagen and cause wrinkled, sagging skin and more fragile joints. It also contributes to the deterioration of vascular and bone structure in older people.
[0010] Boron esters have both anti-inflammatory agents and pain-relieving properties compared to such substances. Arguments that both boric acid and boron esters inhibit the growth of breast cancer cells, but only boron esters to support apoptosis are stated in the literature.
[0011] Boron was approved by the FDA in 2003 for the treatment of one of the most dangerous types of cancer, multiple myeloma (white blood cell cancer).
[0012] Boron has been used by mankind for nearly three centuries in health and nutrition. In particular, BNCT (Boron Neutron Capture Therapy), which is defined as BNCT (Boron Neutron Capture Therapy), has started to be applied today, especially in glioblastoma multiforme type brain tumors, which are known to be highly malignant. Very good results have been obtained.
[0013] At the same time, studies on boron have increased, boron was used as rocket fuel in 1936, and as of 1951 , with the positive results of studies in the field of health with BNCT, the focus has been on the benefits of boron in human health and nutrition.
[0014] It has been shown to be very effective in increasing the bioavailability of all vitamins and minerals by the body, especially vitamins B, D, K and A, which are essential to be taken in sufficient levels by the body, and minerals such as Calcium, Magnesium, Iron, Sodium, Potassium and Zinc. It also increases the effectiveness of our body defense cells that fight diseases. Boron removes free oxygen radicals (SOR), which we can call body toxins, from the body. It is also used in prostate, breast, gastrointestinal and lung cancer treatments.
[0015] It has been found that boron taken with food supplements reduces Ca and Mg excretion by up to 90%. In addition, calcium fructoborate, a boron ester form, was approved as a food supplement by EFSA (European Food Safety Authority) in 2021 . Another boron ester form, sodium citrate boron ester, was added to the Turkish Food Codex as a food supplement active ingredient in 2020.
[0016] FIGURE LIST
[0017] Figure 1. Boron-glucosamine monoester
[0018] Figure 2. Boron-glucosamine diesteri
[0019] Figure 3. Sulfate monoester of boron-chondrite
[0020] Figure 4. Sulfate diester of boron-chondrite
[0021] Figure 5. Schematic representation of the cis-diol
[0022] DETAILED DESCRIPTION OF THE INVENTION
[0023] The invention relates to water-soluble, bio-active boron addition compounds as borate esters of mono-chelate (1 :1 ) and bis-chelate (1 :2) complexes from boric acid and hydroxy-functional biomolecules and their preparation method. Mono-chelate (1 :1 ) is the interaction of the boron element with a bioorganic molecule, resulting in the release of a molecule of water, forming a chemical compound (1 mole organic molecule:1 mole boric acid). Bis-chelate (2:1 ) is the interaction of the boron element with a bioorganic molecule, resulting in the formation of a chemical compound between two molecules of water. (2 moles of organic molecules:1 mol of boric acid).
[0024] Boron cannot be completely metabolized in the human body and most of it is rapidly excreted in the urine. It can be retained in small amounts in body tissues such as bone and spleen. But, the natural boron complexes that are the subject of our invention are the best chemical form for absorption by cells.There have been studies comparing boron and boron esters in the literature. And again, it has been proven in the literature that boron esters are healthier, especially against certain types of cancer and osteoporosis.
[0025] Within the scope of the invention, it has been determined that mono-chelate (1 :1) and bis-chelate (1 :2) complexes of boric acid and hydroxy-functional biomolecules contain negatively charged tetrahedral borate anions balanced with metal cations. Na, K, Mg and Ca ions were used for doping in order to increase their stability by ensuring charge balance, and the reason was chosen for the possibility of using boron in metabolic processes where boron is claimed to be active, in eliminating metal ion, boron and biomolecule deficiencies or in nutritional supplements.
[0026] Chondroitin sulfate and glucosamine 1 :1 and 1 :2 borate complexes, It is formed from the neighbour carboxylate and by coordination over the oxygen of the neighbour hydroxy group to form six-membered chelates.
[0027] Boron ester compounds with boron ester bond (-O-B-O-) and boric acid are transported into cells using the boron-specific carrier NaBC1. The importance of transporting NaBC1 into cells will be explained in this section. Boron is found in all living organisms that perform various biological functions. When these living organisms (microorganisms, plants and animals) were examined, it was discovered that boron was in the form of boron ester instead of boric acid in biological processes. It has been proven that the boron ester form is necessary for healthy biological processes in all living things. Boron esters cannot be synthesized by human metabolism, so they must be obtained from outside (fruits, legumes, leafy vegetables and nuts). These studies also brought about a literature study on the absorption of boric acid and boron esters in the body.
[0028] Evidence has been developed regarding the absorption of boron esters in the body. The first finding is that in humans, all boron ester forms (sorbitol-B-sorbitol, mannitol-B-mannitol, calcium fructoborate, malic acid-B-malic acid, etc.) that it is found in metabolic fluids and tissues mostly as boric acid, first absorbed and then rapidly eliminated through urine that it was quickly eliminated. Along with this, new research has discovered that boron ester molecules reach cells through their bioorganic molecules (sorbitol, mannitol, fructose, malic acid, etc.). While boric acid enters the cell in a limited way through Na pumps (channels), boron ester compounds chelated to the organic ligand via ester bond are absorbed by the cell membrane and enter the cell. Therefore, in order to emphasize and increase the positive effects of boron in cells, boron complex structures with (R-O-B-O-R') ester bonds must be obtained. In the studies available in the literature, synergistic effects of glucosamine and chondritin sulfate molecules and boron supplement taken in dietary supplements have been reported. It has been explained that it has significant positive effects on both glucosamine / chondrite sulphate and boron. Synthesis of boron glucosamine and boron chondrite sulfate monoester / diester molecules, whose reaction mechanisms are given in Figure 1 - Figure 4, is carried out by chelation over the neighbor cis-diol and acidic -OH groups.
[0029] SYNTHESIS OF THE INVENTION
[0030] Boric acid gives an esterification reaction with compounds containing more than one hydroxyl group in its structure (having a cis-diol group) and forms tetrahedral anionic complexes. Partial esterification mono-chelate (1 :1 complex) or bis-chelate (1 :2 complex) structures can be formed with these compounds. Mono-esters of the boron atom are unstable and rapidly hydrolyze to their original components in aqueous media. Di-ester forms are more thermodynamically stable.
[0031] In the synthesis step detailed below, mono-anionic forms of the organic molecule were prepared by reacting acid solutions of NaHCOs, KHCO3, CaCOs and MgCOs in appropriate molarity (stoichiometric ratio).
[0032] While preparing mono-esters, an aqueous solution of 1 mole of boric acid, 1 mole of NaHCO3, KHCO3, one of its salts, and 1 mole of glucosamine or chondrite sulfate organic matter was prepared for the mono-chelate (1 :1 complex). Borate anion (B(OH)4 ) formation is a chemically reversible reaction and due to the interaction between boron species; Boric acid was used to avoid confusion between trigonal and tetrahedral boron type. Boric acid is added to the solution last and the mixing time for glucosamine monoester is 1 .5 hours. If chondritin sulfate mono-ester is being prepared, it takes 3 hours for the boric acid added last to the solution and other chemicals to mix.
[0033] It is important that the pH value is between 5-7. Because boric acid has a tetrahedral structure in neutral aqueous solution. Tetrahedral boric acid pH value between 5-7 affects the yield. The temperature of the solutions is room temperature. After mixing at the optimum value for the organic molecule, salt and boric acid, the solvent of the solution was removed under vacuum and cold acetone was added to the prepared solution to ensure crystallization (precipitation). After vacuum filtration, the precipitate / crystals were immediately placed in a desiccator to prevent moisture absorption.
[0034] While preparing diesters, 1 mole of boric acid, 1 mole of NaHCO3, KHCO3, CaCO3, MgCO3 one of its salts and 2 moles of glucosamine or chondrite sulfate organic matter an aqueous solution of are prepared. The next steps continue the same as the preparation of the mono-esters mentioned above.
[0035] The presence of the esterification bond (R-O-B-O-R'), which is established between the ligand and the boron center in the synthesized molecular structures and facilitates the transport and entry of the boron additive into the cell, is absolutely necessary and must be determined by spectroscopic and chemical analysis.
Claims
CLAIMS1. A nutritional support material containing boron esters characterized by comprising glucosamine or chondrite sulfate and boron esters obtained from boric acid and hydroxy-functional biomolecules.
2. The nutritional support material containing boron esters according to claim 1 , characterized by boric acid and hydroxy-functional biomolecules being monochelate (1 :1 ) and bis-chelate (1 :2) complexes containing negatively charged tetrahedral borate anions balanced with metal cations.
3. The nutritional support material containing boron esters according to claim 2, characterized by boric acid and hydroxy-functional biomolecules comprise Na, K, Mg and Ca ions to increase their stability by ensuring the charge balance of mono-chelate (1 :1) and bis-chelate (1 :2) complexes containing negatively charged tetrahedral borate anions balanced with metal cations.
4. A method to produce a mono-chelate (1 :1 complex) nutritional support material containing boron esters, characterized by comprising the steps below;- Preparing a 1 mole of boric acid, 1 mole of NaHCO3, KHCO3, CaCO3 and MgCO3, one of its salts, and 1 mole of glucosamine or chondrite sulfate organic matter which will be added last and the aqueous solution with a pH value between 5-7,- Mixing for 1 .5 hours if glucosamine is used, and 3 hours if chondrite sulfate is used,- After mixing, removing the solvent of the solution under vacuum,- Ensuring crystallization (precipitation) by adding cold acetone to the prepared solution,- Performing vacuum filtration for precipitates / crystals,- Placing it in a desiccator to prevent it from absorbing moisture.
5. A method to produce a bis-chelate (1 :2 complex) nutritional support material containing boron esters, characterized by comprising the steps below;- Preparing a 1 mole of boric acid, 1 mole of NaHCO3, KHCO3, CaCO3 and MgCO3, one of its salts, and 2 moles of glucosamine or chondrite sulphate organic matter which will be added last and the aqueous solution with a pH value is between 5-7,- Mixing for 1 .5 hours if glucosamine is used, and 3 hours if chondroitin sulfate is used,- After mixing, removing the solvent of the solution under vacuum,- Ensuring crystallization (precipitation) by adding cold acetone to the prepared solution,- Performing vacuum filtration for precipitates / crystals,- Placing it in a desiccator to prevent it from absorbing moisture.
Citation Information
Patent Citations
Composite nano-preparation for treating and recovering osteoarticular functions and preparation method thereof
CN111280447A
